If a pharmaceutical researcher introduces a novel molecule that selectively enhances coactivator binding to estrogen receptors (ER) within a cell nucleus, which consequence follows?

💡 Explanation

Enhancing coactivator binding to nuclear estrogen receptors directly promotes assembly of the transcriptional complex, because this enhances the ability of the receptor to activate gene expression. Therefore, ER-mediated gene transcription increases, rather than other effects such as inhibiting dimerization which is a separate step.

• If cellular ATP production via oxidative phosphorylation decreases, which consequence follows?
• Why does horizontal gene transfer commonly occur between bacteria and archaea, rather than between eukaryotes and prokaryotes?
• A photosynthetic algal cell is treated with a drug inhibiting prokaryotic ribosomes. Which consequence follows for the cell's chloroplast?
• In metabolic syndrome, which mechanism explains why adiponectin levels decrease despite increased fat mass?
• A legume in nitrogen-poor soil forms nodules. Which benefit does the plant gain?
• A flowering plant provides carbohydrates to symbiotic fungi colonizing its roots. Which outcome is most likely to also occur, supporting the plant's growth in nutrient-poor soils?